Outcomes of direct stenting in patients with ST-elevated myocardial infarction

A Kalayci1, V Oduncu2, C Y Karabay2

  • 1Kosuyolu Heart and Research Hospital, Kosuyolu, Turkey. arzukalayci@yahoo.com.

Herz
|June 16, 2017
PubMed

Insights

Direct stenting (DS) during primary percutaneous coronary intervention (P-PCI) for ST-elevated myocardial infarction (STEMI) improved procedural outcomes and long-term survival. However, DS showed similar mortality rates to conventional stenting (CS) in matched patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • ST-elevated myocardial infarction (STEMI) requires prompt treatment.
  • Primary percutaneous coronary intervention (P-PCI) is a standard reperfusion therapy for STEMI.
  • Conventional stenting (CS) involves predilation before stent deployment, while direct stenting (DS) deploys the stent without predilation.

Purpose of the Study:

  • To compare the procedural results and long-term mortality of DS versus CS in patients undergoing P-PCI for STEMI.
  • To evaluate the impact of baseline thrombolysis in myocardial infarction (TIMI) flow grade on outcomes in the CS group.

Main Methods:

  • Retrospective analysis of 2306 patients undergoing P-PCI within 12 hours of symptom onset.
  • Patients were divided into DS (n=597) and CS (n=1709) groups.
  • The CS group was further stratified by baseline TIMI flow grade (≥1 or 0).
  • Prospective follow-up for clinical events, focusing on postprocedural myocardial reperfusion and all-cause mortality.

Main Results:

  • DS group demonstrated superior final TIMI-3 flow, myocardial blush grade 3, and ST-segment resolution.
  • DS was associated with better left ventricular ejection fraction and reduced distal embolization.
  • In-hospital (1.5% vs 4.6%) and long-term all-cause mortality (8.8% vs 17.0%) were significantly lower in the DS group compared to the CS group.
  • Kaplan-Meier analysis revealed similar survival for DS and CS with TIMI flow ≥1, but worse survival for CS with TIMI flow 0.

Conclusions:

  • Direct stenting in P-PCI is linked to improved angiographic outcomes and enhanced long-term survival in STEMI patients.
  • Despite better outcomes, DS demonstrated comparable in-hospital and long-term mortality to matched conventional stenting patients.
  • Baseline TIMI flow grade is a critical determinant of outcomes in conventional stenting for STEMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
346
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
567